Beyond The Numbers: 8 Analysts Discuss Treace Medical Concepts Stock
Portfolio Pulse from Benzinga Insights
Treace Medical Concepts (NASDAQ:TMCI) has been analyzed by 8 analysts over the past three months, showing a range of perspectives from bullish to bearish. The average 12-month price target has decreased by 38.62% to $8.25. Recent analyst actions include both raises and lowers in ratings and price targets, reflecting mixed sentiments.
July 16, 2024 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Treace Medical Concepts has received mixed analyst ratings over the past three months, with a significant decrease in the average 12-month price target to $8.25. Recent actions include both raises and lowers in ratings and price targets, indicating varied sentiments among analysts.
The mixed analyst ratings and significant decrease in the average price target suggest uncertainty about the stock's short-term performance. While some analysts have raised their ratings and targets, others have lowered them, reflecting varied sentiments.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100